Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 14 clinical trials
Romosozumab/Denosumab Study for Premenopausal IOP

premenopausal women treated with teriparatide. The investigators will test this hypothesis in this phase 2 study of 30 premenopausal women with idiopathic osteoporosis (IOP) who will receive 12M of romosozumab

  • 28 views
  • 04 Apr, 2021
  • 2 locations
Novel Combination Therapy for Osteoporosis in Men (Osteo-Men)

Osteoporotic fractures are a key health problem in older men. Although there are drugs approved to treat osteoporosis in men [bisphosphonates, denosumab, and teriparatide (TPTD) or PTH(1-34

  • 39 views
  • 26 Feb, 2022
  • 1 location
Study of Teriparatide in Stress Fracture Healing

Investigation into the use of teriparatide in the treatment of stress fractures. Primary outcome is healing on MRI, secondary outcomes are pain, time spent in rehabilitation and future

  • 0 views
  • 26 Jan, 2021
  • 1 location
Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery

This project aims to investigate any difference of insertional torque strength for osteoporotic patients with preoperative 1-month teriparatide injections versus those without. The increased

bone mineral density
dual-energy x-ray absorptiometry
teriparatide
  • 1 views
  • 27 May, 2022
  • 2 locations
Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab Therapy

The aim of this study is to examine the efficacy and adverse events in the following 3 groups in osteoporosis patients: The administration period of teriparatide is less than 6

denosumab therapy
forteo
teriparatide
denosumab
bone mineral density
  • 130 views
  • 15 Feb, 2022
  • 1 location
Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients

It has not been well known about the changes of bone metabolic markers, bone mineral density and other bone-related markers after teriparatide and/or denosumab treatment in Japanese osteoporotic

denosumab
bone mineral density
teriparatide
  • 39 views
  • 25 Jan, 2021
  • 1 location
Effect of Vitamin K Supplementation on Circulating Levels of Osteocalcin on the Bone Metabolism and Aging (OstMARK)

with vitamin K in association with anabolic treatment with teriparatide will be analyzed not only on bone but also on skeletal muscle and energy metabolism in patients with severe osteoporosis.

teriparatide
primary osteoporosis
osteoporosis
osteocalcin
calcium
  • 0 views
  • 26 May, 2022
  • 1 location
Bisphosphonates for Prevention of Post-Denosumab Bone Loss

idiopathic osteoporosis (IOP) enrolled in AAAN0161 (FD05114) "Denosumab for the prevention of post-teriparatide bone loss in premenopausal women with idiopathic osteoporosis". In addition, the

zoledronic acid
forteo
teriparatide
alendronate
denosumab
  • 78 views
  • 03 Mar, 2022
Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid

the aim of preventing fractures but the evidence base for efficacy is poor. Recent evidence suggests that the bone anabolic agent teriparatide (TPTD) increases bone mineral density (BMD) and may have

care adult
zoledronic acid
teriparatide
bone mineral density
parathyroid hormone
  • 157 views
  • 22 Jan, 2021
  • 25 locations
Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone

This randomized open label clinical trial will evaluate the effect of continued denosumab alone over 18 months versus denosumab with added abaloparatide for 18 months. 70 postmenopausal women will be enrolled over a period of 18 months. The co-primary outcomes will be group differences in bone mineral density (BMD) of …

  • 0 views
  • 23 Feb, 2021
  • 1 location